Avidity Partners Management LP grew its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 18.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 447,434 shares of the company’s stock after acquiring an additional 68,334 shares during the period. Avidity Partners […]
Intellia Therapeutics' (NASDAQ: NTLA) shares gained 10% on Jun 3 after the company reported encouraging long-term data from the phase I portion of its early to mid-stage study evaluating NTLA-2002 for treating hereditary angioedema.
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Contrarius Investment Management Ltd decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 214,401 shares of the company’s stock after selling 17,461 shares during the quarter. Contrarius Investment Management Ltd owned […]